Navigation Links
Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
Date:5/23/2012

MONMOUTH JUNCTION, N.J., May 23, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE® (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.

There have been very few clinical trials to support current NTM treatment recommendations, and no new drugs have been assessed in randomized trials for NTM lung disease in many years.   Additionally, NTM remains a significantly under-diagnosed disease.  TARGET-NTM represents an opportunity to make significant advancement in the awareness and treatment of this debilitating chronic illness, according to Kenneth N. Olivier, M.D., M.P.H., Principal Investigator of the study and staff pulmonologist in the Laboratory of Clinical Infectious Diseases at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

"Current treatment for NTM lung disease requires lengthy multi-drug regimens that can be poorly tolerated and have limited efficacy, especially in patients with severe disease or in those who have failed prior treatment attempts," said David E. Griffith, M.D., lead author of the American Thoracic Society's and the Infectious Disease Society of America's diagnosis and treatment guidelines for NTM, and Professor of Medicine at the University of Texas Health Science Center at Tyler. "If effective, ARIKACE has the potential to significantly impact the current NTM treatment paradigm."  Dr. Griffith, along with Richard J Wallace, M.D., Professor of Medicine and Microbiology, also at the University of Texas Health Science Center at Tyler, are Co-Principal Investigators for the study.

NTM Increasingly Prevalent

According to a
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Insmed Announces First Quarter 2012 Financial Results
2. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
3. Insmed to Host 2012 First Quarter Earnings Conference Call
4. Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call
5. Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
6. Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
7. Insmed Incorporated Provides Regulatory Update
8. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
9. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
10. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
11. Insmed Announces First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 01, 2015 ... announced the addition of the "Elemental Analysis ... ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food ... Global Forecasts to 2020" report to their ... on the basis of types, technologies, and applications. ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the ... to their offering. This patent ... Photoacoustic imaging is a safe, non-invasive, non-ionizing ... and represents a great alternative to traditional ...
(Date:7/7/2015)... , July 7, 2015 Sequent Medical, ... developing innovative devices for the treatment of neurovascular ... has joined its Board of Directors.   ... of medical device and healthcare industries experience.  He ... he has commercialized numerous leading-edge products.  His experience ...
Breaking Medicine Technology:Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... SAN DIEGO, March 20, 2012  HUYA Bioscience International ... of China,s preeminent pharmacological researchers, Prof. Deyong Ye ... an international leader in supporting the global development ... Fudan University will focus on specific innovations coming ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
Cached Medicine Technology:HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 2HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... items, recently launched their first line of luxury smart jewelry called the Socialite™ ... expected to ship this fall. , “The Socialite collection was crafted to ...
(Date:7/7/2015)... ... July 07, 2015 , ... Owners of Green Ladies Cleaning are ... the home service category. This honor can only be gained by votes from Madison ... safety of the products and methods they use daily. Having a home cleaned with ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern ... pass those long, stressful days at work is knowing that there is hopefully a ... back and stress free as imagined. Planning for a vacation can be quite stressful, ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... Business Times highlights rumors about possible facial rejuvenation that have emerged about Hillary ... former U.S. Secretary of State looks more youthful than she has in some ...
(Date:7/7/2015)... ... , ... Greatist today announced the acquisition of Blood, Sweat ... most fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s ... for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, ...
Breaking Medicine News(10 mins):Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2
... Delayed Diagnosis;,Almost Seventy Percent Report Unnecessary or Duplicative Scans , ... ... released today (at RSNA ) uncovers a host of systemic ... demand and negatively impacting patient diagnosis and care. Of those surveyed, ...
... Corporation ("Bally"),today announced that it has filed for voluntary ... filed today in the U.S. Bankruptcy,Court for the Southern ... the chapter,11 process to significantly reduce debt from its ... It expects to accomplish,these goals through either a sale ...
... Company (PRC),the leading manufacturer of Alternative and Augmented ... selected Acapela High,Quality voices to speech empower Vantage(TM) ... Smart, compact, rugged ... device for children and adults who use augmentative,communication. ...
... Decision Resources, one of the,world,s leading research ... finds that the diagnosis and drug treatment of ... remain low through 2012,particularly in rural regions. Although ... 70 percent of the prevalent Alzheimer,s disease,population in ...
... devoted to injury prevention through exercise, has created the first of its ... DVD, hosted by physical therapist Chantal Donnelly, is distributed by the lifestyle ... Relief DVD is perfect for the gift giving season. , ... Los ...
... availability of their trusted point-of-care information on the iPhone and ... ... (PRWEB) December 3, 2008 -- Lexi-Comp, Inc., a provider of ... iPhone and the iPod touch. This latest innovation enhances Lexi-Comp,s ...
Cached Medicine News:Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 4Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 2Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 3Health News:Accessibility: Acapela Group Voice Enables Vantage Lite Innovative AAC Dedicated Device 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc. 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: